CDC42 and Parkinson disease: We, therefore, tested whether CDC42 inhibition by CASIN might potentially rescue the PD-associated motoric decline in α-syn-expressing aged mice and administered it around the age of PD onset (12 M of age) and after age of onset (20 M of age).